组织器官移植对临床输血的挑战与思考

doi:10.3969/j.issn.1671-2587.2021.05.001

临床输血与检验 ›› 2021, Vol. 23 ›› Issue (5): 545-550.DOI: 10.3969/j.issn.1671-2587.2021.05.001

• 组织器官移植输血专题（一） • 下一篇

组织器官移植对临床输血的挑战与思考

尹文

710032 空军军医大学西京医院输血科

收稿日期:2021-07-23 出版日期:2021-10-20 发布日期:2021-10-20
作者简介:尹文（1969-）,男,河南禹州市人,教授,博导,主要从事输血医学的基础和临床研究,（E-mail）yinwen@fmmu.edu.cn。

Challenges and Thoughts Brought by the Development of Transplantation Technology to Clinical Blood Transfusion

YIN Wen

Department of Blood Transfusion, Clinical Laboratory, Xijing Hospital, the Fouth Military Medical University, Xi'an 710032

Received:2021-07-23 Online:2021-10-20 Published:2021-10-20

摘要/Abstract

摘要： 临床输血和输血相关免疫对移植物成活至关重要。随着移植技术的发展,实现了肝移植、肾移植、小肠移植、肺移植、子宫移植、造血干细胞移植,异种器官移植也在积极探索,研究者也逐步对移植相关输血有了新的认识。本文阐述了实体器官移植及造血干细胞移植相关血液免疫学、围术期移植输血管理和异种器官移植未来的关注方向三个方面的内容,以期为移植技术发展过程中临床输血提供新的思路。

关键词: 移植技术, 血型与临床输血, 输血管理, 异种器官移植, 移植免疫学

Abstract: Clinical blood transfusion and blood transfusion-related immunity are critical to the survival of the transplant. With the improvement of transplantation technology, liver transplantation, kidney transplantation, small intestine transplantation,lung transplantation uterus transplantation, hematopoietic stem cell transplantation have been realized, and xenogeneic organ transplantation is also actively exploring. Researchers have gradually gained a new understanding of transplantation-related blood transfusion. This paper expatiated on blood immunology related to organ transplantation and hematopoietic stem cell transplantation, perioperative blood transfusion during transplantation and xenotransplantation in the future, in order to provide new ideas for blood transfusion in transplantation technology.

Key words: Transplantation techniques, Blood group and clinical transfusion, Blood transfusion management, Xenotransplantation, Transplantation immunology

中图分类号:

R457.1

尹文. 组织器官移植对临床输血的挑战与思考[J]. 临床输血与检验, 2021, 23(5): 545-550.

YIN Wen. Challenges and Thoughts Brought by the Development of Transplantation Technology to Clinical Blood Transfusion[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(5): 545-550.

参考文献

[1] 夏爱军,张献清,胡兴斌,等.小肠移植患者ABO血型不合抗体效价监测(附1例报告)[J].中国输血杂志,2014,27(3):294-295.
[2] 汪昶,陈立中,邱江,等.ABO血型不合活体肾移植11例分析[J].器官移植,2019,10(2):182-186.
[3] 吴国生. 临床活体小肠移植国内外研究进展[J].中华结直肠疾病电子杂志,2013,2(5):221-223.
[4] KIMURA F,SATO K,KOBAYASHI S,et al.Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program[J].Haematologica,2008,93(11): 1686-1693.
[5] TEKGÜNDÜZ S A,ÖZBEK N.ABO blood group mismatched hematopoietic stem cell transplantation[J].Transfus Apher Sci,2016,54(1):24-29.
[6] RAMSEY G .Transfusion therapy in solid organ transplantation.In: Simon TL, Dzik WH, Sngder EL( ed) .Rossis Principles of Transfusion Medicine[M].3rd ed, Philadelphia :Lippincott Williams & Wilkins, 2002 .
[7] SIS B.Intragraft donor-specific antibody detection: a new test to dichotomize HLA alloantibodies into high and low injurious activity[J].Am J Transplant,2013,13(11):2787-2789.
[8] SENGUPTA P,BISWAS S,CHOWDHURY S,et al.Passenger lymphocyte syndrome in a renal transplant recipient[J].J Assoc Physicians India,2015,63(12):86-88.
[9] NISHIDE S,UCHIDA J,KABEI K,et al.Passenger lymphocyte syndrome in the ABO-incompatible kidney transplant recipient receiving rituximab[J].Exp Clin Transplant,2019,17(4):558-560.
[10] ROMERO S,SOLVES P,LANCHARRO A,et al.Passenger lymphocyte syndrome in liver transplant recipients: a description of 12 cases[J].Blood Transfus,2015,13(3):423-428.
[11] 明英姿,庄权,成柯,等.肝移植术后过客淋巴细胞综合征的发病机制和研究进展[J].器官移植,2017,8(4):316-319.
[12] 王文婷,张保萍,刘丽娜,等.过客淋巴细胞引起ABO非同型肝移植患者术后发生溶血反应1例[J].中国输血杂志,2016,29(2):207-209.
[13] CYWINSKI J B,ALSTER J M,MILLER C,et al.Prediction of intraoperative transfusion requirements during orthotopic liver transplantation and the influence on postoperative patient survival[J].Anesth Analg,2014,118(2):428-437.
[14] 王淑英,牛国涛,刘振红,等.135例肝移植患者围术期输血情况分析[J].临床输血与检验,2015,17(2): 135-138.
[15] CLEVENGER B,MALLETT S V.Transfusion and coagulation management in liver transplantation[J].World J Gastroenterol,2014,20(20):6146-6158.
[16] OPELZ G,WUJCIAK T.Cadaveric kidneys should be allocated according to the HLA match[J].Transplant Proc,1995,27(1):93-99.
[17] OPELZ G.Repeated HLA mismatches increase the failure rate of second kidney transplants.Collaborative Transplant Study[J].Transplant Proc,1995,27(1): 658-659.
[18] 郎嵘,王桂君,梁晓林,等.尿毒症患者输血对群体反应性抗体产生的影响[J].北京医学,2013,35(4):303-304.
[19] 王洪伟,郁雷,王锡山.小肠移植的研究进展及围手术期的注意要点[J].中华结直肠疾病电子杂志,2014,3(3): 192-194.
[20] 夏爱军,胡兴斌,安群星,等.小肠移植患者围术期成分输血治疗[J].中国输血杂志,2014,27(11):1163-1164.
[21] 欧阳振波,尹倩,全松,等.子宫移植的伦理学探讨[J].现代妇产科进展,2017,26(7):548-549.
[22] 欧阳振波,魏世远,盘翠丽,等.人子宫移植后临床妊娠并成功分娩活产儿案例分析[J].中华妇幼临床医学杂志(电子版),2020,16(1):93-99.
[23] 许金华,李晓丰.ABO血型不合异基因造血干细胞移植后血型转换期的输血策略[J].中国组织工程研究,2015,19(6):913-917.
[24] 杨世明,张勇萍,潘晓莉,等.异基因外周血造血干细胞移植后ABO血型抗原抗体效价的变化[J].细胞与分子免疫学杂志,2010,26(9):933-934.
[25] 曹晓明,田华,要军.ABO血型不合造血干细胞移植后血型转变的临床分析[J].北京医学,2008,30(4):242-243.
[26] LEE J H,LEE J H,CHOI S J,et al.Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation[J].Br J Haematol,2003,120(4):702-710.
[27] STALEY E M,SCHWARTZ J,PHAM H P.An update on ABO incompatible hematopoietic progenitor cell transplantation[J].Transfus Apher Sci,2016,54(3): 337-344.
[28] STUSSI G,HALTER J,BUCHELI E,et al.Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins[J].Haematologica,2009,94(2): 239-248.
[29] OZKURT Z N,YEGIN Z A,YENICESU I,et al.Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation[J].Transplant Proc,2009,41(9):3851-3858.
[30] TRELEAVEN J,GENNERY A,MARSH J,et al.Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force[J].Br J Haematol,2011,152(1):35-51.
[31] 张玄,王琳,张洪涛,等.多基因编辑猪-猴心脏、肝脏、肾脏移植临床前研究初步报道[J].器官移植,2021,12(1):51-56.
[32] YEH H,MACHAIDZE Z,WAMALA I,et al.Increased transfusion-free survival following auxiliary pig liver xenotransplantation[J].Xenotransplantation,2014,21(5):454-464.
[33] ZHANG X,LI X,YANG Z,et al.A review of pig liver xenotransplantation: Current problems and recent progress[J].Xenotransplantation,2019,26(3):e12497.

组织器官移植对临床输血的挑战与思考

Challenges and Thoughts Brought by the Development of Transplantation Technology to Clinical Blood Transfusion

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 5

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	韩春俐, 陈琳. PDCA循环在临床输血申请单书写质量持续改进中的应用[J]. 临床输血与检验, 2018, 20(6): 621-622.
[2]	江晓明,杜平,陈烨. 某三甲综合医院2012~2016年临床用血情况分析[J]. 临床输血与检验, 2018, 20(4): 393-395.
[3]	刘恒旸,王静成,金晓红. 信息系统在护理安全输血规范管理中的应用[J]. 临床输血与检验, 2018, 20(4): 442-444.
[4]	王燕. 浅谈医院合理性用血评价[J]. 临床输血与检验, 2017, 19(4): 355-357.
[5]	孙友岭, 李涛, 徐晶晶, 周涛, 万胜全. 皖北某地31家医院临床输血病历的评价情况分析[J]. 临床输血与检验, 2017, 19(3): 237-239.